LabGenomics Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-21,175	-4,674	48,397	83,855	42,766	962.42
Depreciation & Amortization	8,418	5,896	3,965	3,340	3,427	3,803
Loss (Gain) From Sale of Assets	180.22	-1,409	47.05	-	-	-11.61
Asset Writedown & Restructuring Costs	-8.11	-	-	55.2	1,636	306.41
Loss (Gain) From Sale of Investments	3,128	-1,016	3,959	-2,436	268.91	-253.8
Loss (Gain) on Equity Investments	753.4	677.78	72.11	46.37	26.77	274.33
Stock-Based Compensation	258.84	16.15	47.94	31.78	-	-
Provision & Write-off of Bad Debts	999.03	1,486	174.16	-33.5	527.56	301.02
Other Operating Activities	-3,197	229.79	-17,441	11,708	14,984	1,015
Change in Accounts Receivable	11,319	11,867	36,609	-36,873	-13,748	-2,603
Change in Inventory	-757.47	243.12	2,505	2,088	-5,652	-196.38
Change in Accounts Payable	-3,783	-7,802	-8,427	3,296	3,874	344.74
Change in Unearned Revenue	4.74	10.47	-	-	-	-
Change in Income Taxes	-319.87	-2,912	-	-	-	-
Change in Other Net Operating Assets	-5,665	-6,442	-955.03	284.83	-1,738	-754.09
Operating Cash Flow	-9,844	-3,827	68,955	65,362	46,372	3,188
Operating Cash Flow Growth	-	-	5.50%	40.95%	1354.53%	-
Capital Expenditures	-3,233	-4,990	-37,648	-13,717	-699.21	-560.94
Sale of Property, Plant & Equipment	194.18	7,582	-	19.1	-	43.43
Cash Acquisitions	-83,440	-83,440	-	-	-	-
Divestitures	6,020	6,020	-	-	-	-
Sale (Purchase) of Intangibles	-709.72	-206.59	-682.26	-97.83	-815.81	-1,360
Investment in Securities	63,325	-41,302	-14,940	-15,741	-6,526	1,727
Other Investing Activities	764.64	-204.62	-47.95	3,476	-574.78	64.26
Investing Cash Flow	-17,895	-116,604	-53,317	-26,061	-8,586	-85.82
Long-Term Debt Issued	-	40,000	16,000	3,200	393.58	-
Short-Term Debt Repaid	-	-	-	-2,500	-	-71.45
Long-Term Debt Repaid	-	-4,993	-1,237	-1,351	-1,785	-1,098
Total Debt Repaid	-5,440	-4,993	-1,237	-3,851	-1,785	-1,169
Net Debt Issued (Repaid)	-5,440	35,007	14,763	-650.63	-1,391	-1,169
Issuance of Common Stock	-	22,712	-	-	331.63	-
Repurchase of Common Stock	-	-	-	-6,543	-	-481.73
Dividends Paid	-	-	-3,317	-	-	-
Other Financing Activities	211.5	-72.7	-0	-	100	161.33
Financing Cash Flow	-5,229	57,646	11,445	-7,194	-959.84	-1,490
Foreign Exchange Rate Adjustments	-1,119	349.43	-14.3	-131.83	-988.51	-14.88
Miscellaneous Cash Flow Adjustments	6,249	6,249	913.97	718.62	-	-
Net Cash Flow	-27,838	-56,186	27,982	32,694	35,837	1,598
Free Cash Flow	-13,077	-8,817	31,307	51,645	45,673	2,627
Free Cash Flow Growth	-	-	-39.38%	13.08%	1638.49%	-
Free Cash Flow Margin	-15.32%	-12.06%	21.62%	25.52%	38.23%	7.92%
Free Cash Flow Per Share	-176.18	-119.26	462.30	764.15	693.42	42.30
Cash Interest Paid	1,964	1,658	498.73	118.93	138.53	162.03
Cash Income Tax Paid	6,277	3,874	32,565	11,929	-27.78	34.13
Levered Free Cash Flow	-14,788	869.72	20,219	35,699	35,749	-
Unlevered Free Cash Flow	-11,488	3,976	20,578	35,829	35,889	-
Change in Net Working Capital	4,437	-7,507	-13,520	19,049	339.56	-

Source: S&P Capital IQ. Standard template. Financial Sources.